Key result
AF and RV dysfunction serve as key prognostic markers in cardiovascular progression to HF.
Cardiovascular diseases remain the dominant contributor to the global disease burden.
AF and RV dysfunction merit prognostic attention in CVD-HF progression; leaves open prospective validation trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Floria et al. (2026) conducted an editorial in Patients with cardiovascular disease including atrial fibrillation and right ventricular dysfunction progressing to heart failure. This editorial summarizes that atrial fibrillation and right ventricular dysfunction are key prognostic markers in the cardiovascular disease continuum progressing to heart failure without specific quantitative trial data.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: